Your browser doesn't support javascript.
loading
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.
Gowen, Michael F; Giles, Keith M; Simpson, Danny; Tchack, Jeremy; Zhou, Hua; Moran, Una; Dawood, Zarmeena; Pavlick, Anna C; Hu, Shaohui; Wilson, Melissa A; Zhong, Hua; Krogsgaard, Michelle; Kirchhoff, Tomas; Osman, Iman.
Afiliación
  • Gowen MF; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.
  • Giles KM; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.
  • Simpson D; Division of Epidemiology, New York University School of Medicine, New York, NY, USA.
  • Tchack J; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.
  • Zhou H; Applied Bioinformatics Core, New York University School of Medicine, New York, NY, USA.
  • Moran U; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.
  • Dawood Z; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.
  • Pavlick AC; Division of Hematology & Oncology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.
  • Hu S; CDI Laboratories, Baltimore, MD, USA.
  • Wilson MA; Division of Hematology & Oncology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.
  • Zhong H; Department of Population Health, New York University School of Medicine, New York, NY, USA.
  • Krogsgaard M; Department of Pathology, New York University School of Medicine, 522 First Ave., Smilow Research Building 1311, New York, NY, 10016, USA. michelle.krogsgaard@nyumc.org.
  • Kirchhoff T; Division of Epidemiology, New York University School of Medicine, New York, NY, USA.
  • Osman I; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA. iman.osman@nyumc.org.
J Transl Med ; 16(1): 82, 2018 04 02.
Article en En | MEDLINE | ID: mdl-29606147
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia / Melanoma / Anticuerpos Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Transl Med Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia / Melanoma / Anticuerpos Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Transl Med Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos